SEC 13F Intelligence

Eventide Asset Management, LLC / PCVX

Eventide Asset Management, LLC’s Vaxcyte Inc Position

Does Eventide Asset Management, LLC own Vaxcyte Inc (PCVX)? Yes — 1.37M shares worth $80M (+1.32% of its 13F portfolio) as of Q1 2026, up from 917.1K shares the prior filed quarter.

Position Value
$80M
Q1 2026
Shares
1.37M
% of Portfolio
+1.32%
Quarters Held
11
currently held

Position History PCVX

Reported value by quarter
Q3 ’23: $20MQ3 ’23Q4 ’23: $38MQ1 ’24: $45MQ1 ’24Q2 ’24: $56MQ3 ’24: $44MQ3 ’24Q4 ’24: $31MQ1 ’25: $18MQ1 ’25Q2 ’25: $28MQ3 ’25: $14MQ3 ’25Q4 ’25: $42MQ1 ’26: $80MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.37M$80M+1.32%
Q4 2025917.1K$42M+0.66%
Q3 2025379.3K$14M+0.22%
Q2 2025848.1K$28M+0.48%
Q1 2025470.2K$18M+0.35%
Q4 2024383.5K$31M+0.57%
Q3 2024383.5K$44M+0.76%
Q2 2024739.2K$56M+0.96%
Q1 2024657.2K$45M+0.70%
Q4 2023607.2K$38M+0.62%
Q3 2023393.0K$20M+0.36%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Eventide Asset Management, LLC’s full portfolio or all institutional holders of PCVX.